|Bid||0.0000 x 1000|
|Ask||0.0000 x 800|
|Day's range||2.8317 - 3.0200|
|52-week range||1.1800 - 4.2100|
|Beta (5Y monthly)||1.53|
|PE ratio (TTM)||N/A|
|Earnings date||15 Mar 2023 - 20 Mar 2023|
|Forward dividend & yield||N/A (N/A)|
|1y target est||6.75|
A look at the shareholders of Black Diamond Therapeutics, Inc. ( NASDAQ:BDTX ) can tell us which group is most...
Black Diamond (BDTX) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
Insiders who bought US$61k worth of Black Diamond Therapeutics, Inc.'s ( NASDAQ:BDTX ) stock at an average buy price of...